Esperovax
Plymouth
About Esperovax
Esperovax is a biotechnology company specializing in a unique, proprietary platform that produces and delivers targeted mRNA oral biologic medicines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Grant (Oct 2023)
- Website: esperovax.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/esperovax-68552 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.